MyAverix Finance
F · Healthcare
Chosa Oncology AB (W5L)
Biotechnology
Chosa Oncology AB (W5L) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for W5L
Chosa Oncology AB (W5L) — FAQ
What is W5L's P/E ratio?
The price-to-earnings (P/E) ratio for Chosa Oncology AB (W5L) is 25.00 (data as of 2026-05-21).
Does Chosa Oncology AB pay a dividend?
Dividend yield is not available in the current snapshot for Chosa Oncology AB (W5L). Check the MyAverix Finance app for the latest dividend data.
What sector is Chosa Oncology AB in?
Chosa Oncology AB (W5L) is classified in the Healthcare sector (Biotechnology industry).
What exchange is W5L listed on?
W5L is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.